Download Partnerships: AMP and PACT PDF

Table of Contents

                            Partnerships: AMP and PACTFrancis S. Collins, M.D., Ph.D.Director, National Institutes of HealthAdvisory Committee to the DirectorJune 9, 2017
	Accelerating Medicines Partnership (AMP)
	AMP: Overview
	Table of research participants
	AMP: Alzheimer’s Disease (AD)
	AMP: Type 2 Diabetes (T2D)
	AMP: Rheumatoid Arthritis and Systemic Lupus Erythematosus (RA/SLE)
	AMP: Parkinson’s Disease (PD)The newest kid on the blockPartners: GSK, MJFF, NINDS, Pfizer, Sanofi, Verily
	Cancer Moonshot: Partnership for Accelerating Cancer Therapies (PACT)
	Challenges in Developing Immunotherapy and Combination Therapies for Cancer
	Partnership for Accelerating Cancer Therapies (PACT): Initial Design Effort
	PACT: Initial Focus on Two Programs
	PACT: 2017 Next Steps
	What’s Next?
		Case for a Public-Private Partnership for Pain and Opioid Use Disorders
		Planning for Public-Private Partnership for Pain and Opioid Use Disorders
		Public-Private Partnerships:Lessons Learned
	NIH...Turning Discovery Into Health